Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
C4 Pathway and CAM01:27

C4 Pathway and CAM

45.8K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
45.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

6.5K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medicinal Plant-Based Naturopathy and Its Therapeutic Potential: A Systematic Review of Clinical and Life Science Evidence.

Cureus·2026
Same author

Entacapone Ameliorates MASLD by Inhibiting FTO Demethylase Activity.

Drug development research·2026
Same author

Plasma metabolomics identifies trimethylamine N-oxide as an accelerator of gallstone disease accompanied by early neoplastic alterations in mice.

American journal of physiology. Gastrointestinal and liver physiology·2026
Same author

Retinal Pericytes and Their Role in Proliferative Retinopathies.

The American journal of pathology·2026
Same author

Development and Characterization of a Novel Congenital Acute Erythroid Leukemia Cell Line with Unique Features.

Cancers·2026
Same author

A Study on Electrocardiography Echocardiography and Cardiac Biomarkers in Aluminium Phosphide Poisoning and Their Prognostic Correlation.

The Journal of the Association of Physicians of India·2026

Related Experiment Video

Updated: Jul 30, 2025

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
09:16

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro

Published on: November 26, 2018

7.1K

Vascular cell-adhesion molecule 1 (VCAM-1) regulates JunB-mediated IL-8/CXCL1 expression and pathological

Geetika Kaur1,2, Deepti Sharma1,2, Shivantika Bisen1,2

  • 1Integrative Biosciences Center, Wayne State University, Detroit, MI, 48202, USA.

Communications Biology
|May 13, 2023
PubMed
Summary

Interleukin-33 (IL-33) regulates vascular cell adhesion molecule-1 (VCAM-1) in the eye. Targeting VCAM-1-JunB-IL-8 signaling may treat proliferative retinopathies by reducing retinal neovascularization.

More Related Videos

A Method for Labeling Vasculature in Embryonic Mice
09:58

A Method for Labeling Vasculature in Embryonic Mice

Published on: October 7, 2011

15.7K
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

9.8K

Related Experiment Videos

Last Updated: Jul 30, 2025

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
09:16

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro

Published on: November 26, 2018

7.1K
A Method for Labeling Vasculature in Embryonic Mice
09:58

A Method for Labeling Vasculature in Embryonic Mice

Published on: October 7, 2011

15.7K
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

9.8K

Area of Science:

  • Ophthalmology
  • Immunology
  • Molecular Biology

Background:

  • Vascular adhesion molecules are crucial in immunological disorders and cancers.
  • Their role in proliferative retinopathies remains largely unexplored.
  • Interleukin-33 (IL-33) influences vascular cell adhesion molecule-1 (VCAM-1) expression.

Purpose of the Study:

  • To investigate the role of IL-33 and VCAM-1 in retinal neovascularization.
  • To elucidate the VCAM-1-JunB-IL-8 signaling pathway in retinal angiogenesis.
  • To assess the therapeutic potential of targeting this pathway in oxygen-induced retinopathy (OIR).

Main Methods:

  • Studied IL-33 regulation of VCAM-1 in human retinal endothelial cells.
  • Utilized IL-33 genetic deletion in C57BL/6 mice to assess hypoxia-induced VCAM-1 and neovascularization.
  • Analyzed VCAM-1's regulation of IL-8 promoter activity and expression via JunB.
  • Performed RNA sequencing on hypoxic retinas.
  • Administered VCAM-1 siRNA intravitreally in a mouse model of OIR.

Main Results:

  • IL-33 regulates VCAM-1 expression in human retinal endothelial cells.
  • IL-33 deletion reduced hypoxia-induced VCAM-1 expression and retinal neovascularization in mice.
  • VCAM-1, via JunB, regulates IL-8 promoter activity and expression, impacting endothelial cell sprouting and angiogenesis.
  • VCAM-1-JunB-IL-8 signaling was induced in hypoxic retinas.
  • VCAM-1 siRNA reduced hypoxia-induced signaling and OIR-induced retinal neovascularization.

Conclusions:

  • VCAM-1-JunB-IL-8 signaling is a critical mediator of retinal neovascularization.
  • Antagonizing this pathway presents a potential therapeutic strategy for proliferative retinopathies.
  • IL-33 plays a significant role in regulating VCAM-1 in the context of retinal neovascularization.